- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
- 20-F Annual report (foreign)
- 8.1 List of Subsidiaries
- 12.1 CEO Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 12.2 CFO Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 13.1 CEO Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 13.2 CFO Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 15.1 Consent of KPMG, Independent Registered Public Accounting Firm
- 15.2 Consent of Pricewaterhousecoopers Zhong Tian Cpas Limited Company
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
China Medical Technologies, Inc.:
We consent to the incorporation by reference in the registration statement (No. 333-152937) on Form F-3 and the registration statement (No. 333-138954) on Form S-8 of China Medical Technologies, Inc. of our report dated June 27, 2008, except for Note 9 and Note 21, which are as of September 30, 2009, and Note 2(y), which is as of September 8, 2010, with respect to the consolidated statements of income, shareholders’ equity and comprehensive income and cash flows of China Medical Technologies, Inc. for the year ended March 31, 2008, which report appears in the March 31, 2010 annual report on Form 20-F of China Medical Technologies, Inc.
Our report refers to a retrospective change in method of accounting for convertible notes.
/s/KPMG |
Hong Kong, China
September 8, 2010 |